Antimicrobial peptide cathelicidin LL-37 preserves intestinal barrier and organ function in rats with heat stroke.
Shih. Chih-Chin CC; Liao. Wei-Chieh WC; Ke. Hung-Yen HY; Kuo. Chia-Wen CW; Tsao. Cheng-Ming CM; Tsai. Wen-Chiuan WC; Chiu. Yi-Lin YL; Huang. Hsieh-Chou HC; Wu. Chin-Chen CC
Key Findings
- LL‑37 treatment reduced intestinal cell damage and preserved goblet cell function in heat‑stressed rats
- Treated rats showed lower systemic inflammation, nitric oxide levels, and better organ function, leading to higher survival rates
- LL‑37 increased mucin‑2 and Nrf2 expression while decreasing COX‑2 and FITC‑dextran leakage, indicating stronger gut barrier integrity
Practical Outcomes
- The study suggests that enhancing LL‑37 activity could be a strategy to protect against heat‑related gut injury, but it’s only been tested in rats. For biohackers, focusing on ways to naturally raise LL‑37 (e.g., vitamin D optimization) might be the most practical angle, while waiting for human safety and dosing data before considering any direct peptide supplementation.
Summary
In rats that were overheated to mimic heat stroke, giving the natural antimicrobial peptide LL‑37 helped keep the gut lining intact, lowered inflammation and nitrosative stress, and improved survival. The peptide protected gut cells that make mucus and boosted protective proteins, which together reduced leakage of harmful substances into the bloodstream.
Abstract
Global warming increases the incidence of heat stroke (HS) and HS causes the reduction of visceral blood flow during hyperthermia, leading to intestinal barrier disruption, microbial translocation, systemic inflammation and multiple organ failure. Cathelicidin LL-37 exhibits antimicrobial activities, helps innate immunity within the gut to maintain intestinal homeostasis, and augments intestinal wound healing and barrier function. Thus, we evaluated the effects and possible mechanisms of cathelicidin LL-37 on HS. Wistar rats were placed in a heating-chamber of 42 ̊C to induce HS. Changes in rectal temperature, hemodynamic parameters, and survival rate were measured during the experimental period. Blood samples and ilea were collected to analyze the effects of LL-37 on systemic inflammation, multiple organ dysfunction, and intestinal injury. Furthermore, LS174T and HT-29 cells were used to assess the underlying mechanisms. Our data showed cathelicidin LL-37 ameliorated the damage of intestinal cells induced by HS. Intestinal injury, systemic inflammation, and nitrosative stress (high nitric oxide level) caused by continuous hyperthermia were attenuated in HS rats treated with cathelicidin LL-37, and hence, improved multiple organ dysfunction, coagulopathy, and survival rate. These beneficial effects of cathelicidin LL-37 were attributed to the protection of intestinal goblet cells (by increasing transepithelial resistance, mucin-2 and Nrf2 expression) and the improvement of intestinal barrier function (less cyclooxygenase-2 expression and FITC-dextran translocation). Interestingly, high cathelicidin expression in the ileal samples of inflammatory bowel disease patients was associated with better clinical outcome. These results suggest that cathelicidin LL-37 could prevent heat stress-induced intestinal damage and heat-related illnesses.
Study Information
pubmed
2023
2023-03-21T00:00:00.000Z
10.1016/j.biopha.2023.114565
14
68